Antiviral Chemotherapy Discovery of antiviral drugs Targets of antiviral drugs.

Slides:



Advertisements
Similar presentations
HIV and its lifecycle Sources: Wikipedia, HIV is a retrovirus (enveloped viruses possessing an RNA genome,
Advertisements

Chemistry: An Introduction to General, Organic, and Biological Chemistry, Twelfth Edition© 2015 Pearson Education, Inc Viruses HIV causes AIDS, which.
Treatment of AIDS “Antiretroviral therapy & vaccines”
1 Antiviral Drugs Limited selective toxicity –Viruses mostly use host cell machinery, so very few unique targets –Most drugs block steps that take place.
THE REPLICATION OF VIRUSES Virology Lecture 2 Three lectures dealing with (1) replication of DNA viruses (2) the culture, growth and recognition of virus.
Antivirals Slackers Facts by Mike Ori. Disclaimer The information represents my understanding only so errors and omissions are probably rampant. It has.
80% Influenza A — H3N2 (some H1N1) 20 % influenza B (orthomyoxiviridae – seals and humans only) Deaths above epidemic threshold – 50% hospitalizations.
HIV and AIDS Human Immunodeficiency Virus (HIV) is the virus that causes Acquired Immunodeficiency Syndrome (AIDS).
VIRUS ENTRY.
Vaccines and Antivirals. Clinical Use of Interferon Therefore they have been used in the treatment of cancers of various types. Therefore they have been.
HOST DEFENSE AGAINST VIRAL INFECTION- ANIMALS
1 Inhibitors of Other Viruses A. RIBAVIRIN Ribavirin (Virazole) is a nucleoside analogue in which a triazolecarboxamide moiety is substituted on place.
Lecture 29: Viruses 0.5 m.
ANTIVIRAL AND ANTIRETROVIRAL DRUGS 1 University Of Nairobi Department Of Public Health, Pharmacology & Toxicology JPT 341 Pharmacology &Toxicology BVM.
HIV Structure, Lifecycle, and Replication
Lecture 27 Pharmacology Flint et al., Chapter 19, pp. 725 – 757.
Antiviral Agents, chapter 39 Different living organisms.
1 Mukund Modak, Ph. D. Dental Biochemistry 2013 Lecture 39.
Chemistry: An Introduction to General, Organic, and Biological Chemistry, Eleventh Edition Copyright © 2012 by Pearson Education, Inc. Chapter 17 Nucleic.
Antiviral Agents.
Antiviral Agents Upton D. Allen. Outline of Presentation Herpes group agents Anti-influenza agents Anti-hepatitis agents Anti-RSV Immune response modifiers.
Antiviral Agents Restricted spectrum
Anti-HIV Drugs Melissa Morgan Medicinal Chemistry November 23, 2004.
27 MAR 2007 Antiviral Drugs: An Overview Chris Brooks CHEM 5398 Medicinal Chemistry Prof. Buynak.
Influenza A/H1N1 W. Rose H1N1 is a subtype of influenza type A Influenza types B and C also exist but less common, less infectious, and drift.
Virology – Antivirals 1 JU- 2 nd Year Medical Students By Dr Hamed AlZoubi – Microbiology and Immunology Department – Mutah University. MBBS (J.U.S.T)
Antiviral Drugs: An Overview Prof. Sri Agus Sudjarwo.,Ph.D.
What are three different types of viral capsids?.
VIRUSES NONLIVING PARTICLES. Viruses  Smaller than bacteria  Known since late 1800’s but no way to study them  1935 Tobacco mosaic virus was crystallized.
Antivirals. Structure of a Virus all viruses- o have a central core of DNA or RNA o surrounded by a coat(capsid) of packed protein units(capsomers) UNLIKE.
Medicines and Drugs Anti-virals Julia Barnes Anna Cruickshank.
Learning Objectives: Nucleic Acid therapeutics ReadingChapter 4, p from Blackburn & Gait Know the general mechanisms of the anti-cancer drugs.
The head of a pin can hold five hundred million rhinoviruses (cause of the common cold). One sneeze can generate an aerosol of enough cold viruses to.
The head of a pin can hold five hundred million rhinoviruses (cause of the common cold). One sneeze can generate an aerosol of enough cold viruses to infect.
Anti-viral Drugs.. Introduction The viral agents kill viruses by inhibiting their ability to replicate, but there are currently only about a dozen such.
Antiviral Drugs. Mechanism of Action Picornaviruses eg, polioviruses, cold viruses Block attachment molecule on host cell or pathogen Attachment antagonists.
ANTIVIRAL AGENTS FOR THE PREVENTION AND TREATMENT ON INFLUENZA.
Antiviral Agents, chapter 39 Different living organisms.
The Life and Times of Anitvirals By: Karen Summers Louise Pilsbury Jasmine Delaine Irfan Mekic Bethannie Jamerson.
Anti-viral drugs By Dr.Mohamed Abd ALMoneim Attia.
HIV Life Cycle Step 1: Fusion Step 2: Transcription reverse transcriptase Step 3: Integration Step 4: Cleavage Step 5: Packaging and Budding HIV.
 Recognition  Attachment  Penetration  Uncoating  Early protein synthesis  Nucleic acid synthesis  Late protein synthesis  Assembly  Release.
Two different therapeutic approaches for treating: A.A DNA virus (e.g. Herpes) B.An RNA virus (e.g. Influenza)
Antivirals Lect 7,8 Sadia Anjum. Targets for Anti-viral therapy 1. viral attachment to cell and fusion (fusion inhibitors) 2. protein translation in infected.
The head of a pin can hold five hundred million rhinoviruses (cause of the common cold). One sneeze can generate an aerosol of enough cold viruses to infect.
Antiviral drugs.
Chapter 6 - Viruses Obligate Intracellular Parasites – only demonstrate characteristics of life while “inside” a host cell: Bacteria, animal, plant.
Acyclovir Lee, sang-hwi.
Antiviral Therapy. Table for antiviral Drug:Viruses: Chemical Type: Target: Acyclovir, VidarabineHerpesviruses (HSV) Nucleoside analogues Virus polymerase.
Antiviral Agents Dr. Yunita Sari Pane, MS 06 August DEPARTEMEN FARMAKOLOGI & TERAPEUTIK FK USU.
General, Organic, and Biological Chemistry Copyright © 2010 Pearson Education, Inc Viruses Chapter 21 Nucleic Acids and Protein Synthesis.
Viro100: Virology 3 Credit hours NUST Centre of Virology & Immunology
Virology – Antivirals 2 JU- 2 nd Year Medical Students By Dr Hamed AlZoubi – Microbiology and Immunology Department – Mutah University. MBBS (J.U.S.T)
Antiviral agents Hamzeh Elayan
Antiviral Drugs Viruses are obligate intracellular parasites.
Oseltamivir Neuraminidase inhibitor
Good teaching is more a giving of right questions than a giving of right answers. – Josef Albers Viruses Chapter 19.
THE INFECTIOUS PROCESS FOR A VIRUS Despite their simplicity relative to bacteria, viruses still possess various biochemical targets for potential attack.
CONTROL OF VIRAL DISEASES BY IMMUNIZATION
NUCLEIC ACIDS AS DRUG TARGETS
Antiviral chemotherapy
Antiviral Drugs.
Antiviral drugs Mr. OLORO JOSEPH..
Bacteria and Viruses Viruses.
Principles of Pharmacology The Pathophysiologic Basis of Drug Therapy
Bacteria and Viruses Viruses.
Antiviral Drugs Viruses are obligate intracellular parasites.
Antiviral agents.
Antiviral Agents Mr. Sachin Shinde S. M. Joshi College Hadapsar, Pune
Antiviral chemotherapy
Presentation transcript:

Antiviral Chemotherapy Discovery of antiviral drugs Targets of antiviral drugs

 Discovery of antiviral drugs  “Serendipity”—trying out compounds used for other purposes (amantadine and acyclovir).  Chemical modification of known active compounds (ganciclovir and azidothymidine).  High throughput screening assays of many compounds (nevirapine).  Rational design, often with the aid of three- dimensional structures of viral proteins (ritonavir and zanamivir). Antiviral Chemotherapy

 Targets of antiviral drugs  Capsid-binding drugs: picornavirus capsid proteins (attachment/entry).  Uncoating inhibitors: influenza M2 ion channel (uncoating).  Nucleoside analogues: viral DNA and RNA polymerases (genome replication):  May be selectively phosphorylated by virus-encoded kinases  Selectively inhibit viral DNA polymerases  Protease inhibitors: HIV-1 protease (virion maturation).  Neuraminidase inhibitors: influenza neuraminidase (virion release). Antiviral Chemotherapy

 The discovery and widespread use of antiviral compounds began only recently  Importance of antiviral drugs for basic science  How are antiviral drugs obtained?  cell-based high throughput screen  target-based high throughput screen Antiviral Chemotherapy

 Targeting drugs to specific steps of virus infection Fig Inhibitors useful at different stages in virus replication cycle. Antiviral Chemotherapy

 Capsid-binding drugs prevent attachment and entry of virions Antiviral Chemotherapy

 Amantadine blocks ion channels and inhibits uncoating of influenza virions Fig Proposed mechanism of action of amantadine on influenza virus uncoating. Antiviral Chemotherapy (a)Stucture of amantadine. (b)Structure of influenza virus particle (c)Influenza virions in endosomes undergo fusion with endosomal membrane upon drop in pH induced by an endosomal proton pump. The M2 protein allows hydrogen ions to enter virion, releasing the RNP from the matrix protein. Amantadine blocks the M2 channel, inhibiting this process.

 Nucleoside analogues target viral DNA polymerases Fig Structures of selected nucleosides and nucleoside analogues. Antiviral Chemotherapy

 Acyclovir is selectively phosphorylated by herpesvirus thymidine kinases Fig Phosphorylation of acyclovir. Antiviral Chemotherapy

 Acyclovir is preferentially incorporated by herpesvirus DNA polymerases Fig Mechanism of inhibition of herpes simplex virus DNA polymerase by acyclovir triphosphate. Antiviral Chemotherapy

 Cytomegalovirus encodes a protein kinase that phosphorylates ganciclovir  HIV-1 reverse transcriptase preferentially incorporates azidothymidine into DNA, leading to chain termination Antiviral Chemotherapy

Fig Phosphorylation of azidothymidine. Antiviral Chemotherapy

 Nonnucleoside inhibitors selectively target viral replication enzymes Fig Nevirapine, a nonnucleoside inhibitor of HIV-1 reverse transcriptase. Antiviral Chemotherapy

 Protease inhibitors can interfere with virus assembly and maturation  Ritonavir: a successful protease inhibitor of HIV-1 that was developed by rational methods Fig Steps in the development of ritonavir. Antiviral Chemotherapy

 Neuraminidase inhibitors inhibit release and spread of influenza virus Antiviral Chemotherapy

 Antiviral chemotherapy shows promise for the future Antiviral Chemotherapy

Key Terms  Acyclic  Acyclovir  Amantadine  Azidothymidine  Capsid-binding drugs  Cell-based high throughput screen  Enfuvirtide  Ganciclovir  Gangliosides  Interferon  Neuraminidase  Nevirapine  Nonnucleoside inhibitors  Nucleoside diphosphate kinase  Oseltamivir  Peptidomimetic  Pharmacokinetics  Pleconaril  Rational drug discovery  Ritonavir  Sialic acid  Target-based high throughput screen  Therapeutic index  Thymidine kinase  Thymidylate kinase  Zanamivir